Two cartoon medicine bottles on white background

Saskatchewan Biosimilars Initiative

CDHF

Written by: CDHF

Updated: November 8th, 2022

What is Changing in the Saskatchewan Coverage for Biologics?

The Saskatchewan Biosimilars Initiative was announced on October 20, 2022, to improve the uptake of biosimilar drugs.

The Government of Saskatchewan is implementing some changes to their biologics coverage. By April 2023, patients who are already using a reference biologic with an available biosimilar version will be required to start using a biosimilar to keep their coverage under the Saskatchewan Drug Plan. This initiative follows similar efforts elsewhere in Canada namely British Columbia, Alberta, Quebec, New Brunswick, and Northwest Territories. Tens of thousands of Canadians have safely switched to a biosimilar in those initiatives. They are also used extensively in Europe, where countries have had over 15 years of experience with biosimilars.

To switch to a biosimilar, you should:

If you receive additional medication coverage from a third-party insurance provider:

Are there exemptions to the switch?

In some cases, patients may need to continue using the reference biologic for medical reasons. Exemptions to the initiative will be considered on a case-by-case basis. Health care providers can submit a request along with clinical information on behalf of their patient through the exemption request form.

Learn more about the Saskatchewan Biosimilars Initiative here.

Related Articles:

View all News & Articles

Test tubes of a drug

Switching from a Biologic to a Biosimilar Drug in Canada

Two cartoon medicine bottles on white background

Saskatchewan Biosimilars Initiative

Biosimilars Initiatives Banner

Biosimilars Initiatives

British Columbia Flag marking a map of Canada

BC Biosimilars Initiative: Phase Two Information

Map of Alberta close up

Alberta Health Biosimilars Initiative

Two cartoon medicine bottles on white background

Nova Scotia Biosimilar Initiative

CDHF Talks: Dietary Updates and Recommendations for the IBD Patient on a Biosimilar

Two cartoon medicine bottles on white background

Quebec Biosimilars Initiative

Flag of New Brunswick on a pin stuck on a map showing New Brunswick

New Brunswick Biosimilars Initiative

IBD Animation

Switching from a Biologic to a Biosimilar

What’s Health Canada Saying about Biosimilars?

Teen boy talking to doctor

Biosimilars for IBD: Making the Transition Webinar

CDHF Talks: Your New Infusion Clinic